Company: SGBAF
Filing Date: 2025-04-29
Form Type: F-4
Source: 0001193125-25-103898
Chunk: 345

Company: SES S.A.
Filing Date: 2025-04-29
Form: F-4
Chunk 345
---
: EUR 12 million) was expensed in 2024 reflecting a decrease in the impairment of trade and other receivables. This amount is recorded in ‘Other operating expenses’ and includes a reversal of provision of EUR 33 million (2023: EUR 30 million) mainly related to cash collections in respect of trade receivable balances previously provisioned. As of December 31, 2024, trade and other receivables with a nominal amount of EUR 114 million (2023: EUR 114 million) were impaired. Movements in the provision for the impairment of trade and other receivables were as follows:

| € million                      |     | 2024 |     |   |     | 2023 |     |   |
| Balance as of January 1        |     |      | 114 |   |     |      | 114 |   |
| Increase in provision          |     |      |  39 |   |     |      |  42 |   |
| Reversals of provision         |     |      | (33 | ) |     |      | (30 | ) |
| Utilised                       |     |      | (10 | ) |     |      |  (5 | ) |
| Other movements                |     |      |   — |   |     |      |  (3 | ) |
| Impact of currency translation |     |      |   4 |   |     |      |  (4 | ) |
| Balance as of December 31      |     |      | 114 |   |     |      | 114 |   |

Note 21—Financial instruments Fair value estimation and hierarchy The Group uses the following hierarchy levels for determining the fair value of financial instruments by valuation technique: Level 1—Quoted prices in active markets for identical assets or liabilities; Level 2—Other techniques for which all inputs which have a significant effect on the recorded fair value are observable either directly or indirectly; Level 3—Techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data. The fair value of investments that are actively traded in organized financial markets is determined by reference to quoted market bid prices at the close of business on the reporting date. For investments where there is no active market, fair value is determined using valuation techniques. Such techniques include using F-64

Consolidated financial statements as of and for the years ended December 31, 2024,